仁恆實業控股(03628.HK)與南京理工大學北方研究院達成戰略合作
格隆匯1月7日丨仁恆實業控股(03628.HK)宣佈,於2020年1月7日,公司與南京理工大學北方研究院簽訂一份戰略合作協議。根據戰略協議,公司將與南京理工大學北方研究院建立長期戰略伙伴關係,充分發揮各自優勢,整合資源,為智能科技市場的發展做出積極貢獻,以及實現資源分享與共同發展的戰略目標。
戰略協議旨在利用雙方各自優勢及資源展開雙方合作,互惠互利,共同發展,秉承市場化運作方式,雙方致力於達成長期穩定的合作。公司董事會相信通過該戰略合作,集團的資產負債結構將得到改善,集團的盈利能力的穩定性亦將提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.